Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 588

1.

A GM1b/asialo-GM1 oligosaccharide-binding R-type lectin from purplish bifurcate mussels Mytilisepta virgata and its effect on MAP kinases.

Fujii Y, Gerdol M, Kawsar SMA, Hasan I, Spazzali F, Yoshida T, Ogawa Y, Rajia S, Kamata K, Koide Y, Sugawara S, Hosono M, Tame JRH, Fujita H, Pallavicini A, Ozeki Y.

FEBS J. 2019 Nov 26. doi: 10.1111/febs.15154. [Epub ahead of print]

PMID:
31769916
2.

Phase II study of S-1 in patients with previously-treated invasive thymoma and thymic carcinoma: North Japan lung cancer study group trial 1203.

Tsukita Y, Inoue A, Sugawara S, Kuyama S, Nakagawa T, Harada D, Tanaka H, Watanabe K, Mori Y, Harada T, Hino T, Fujii M, Ichinose M.

Lung Cancer. 2019 Oct 18;139:89-93. doi: 10.1016/j.lungcan.2019.10.016. [Epub ahead of print]

PMID:
31751805
3.

Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti-Programmed Cell Death 1 Monotherapy for Advanced Non-Small Cell Lung Cancer.

Aso M, Toi Y, Sugisaka J, Aiba T, Kawana S, Saito R, Ogasawara T, Tsurumi K, Ono K, Shimizu H, Domeki Y, Terayama K, Kawashima Y, Nakamura A, Yamanda S, Kimura Y, Honda Y, Sugawara S.

Oncologist. 2019 Nov 7. pii: theoncologist.2019-0550. doi: 10.1634/theoncologist.2019-0550. [Epub ahead of print]

PMID:
31699903
4.

Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study.

Hosomi Y, Morita S, Sugawara S, Kato T, Fukuhara T, Gemma A, Takahashi K, Fujita Y, Harada T, Minato K, Takamura K, Hagiwara K, Kobayashi K, Nukiwa T, Inoue A; North-East Japan Study Group.

J Clin Oncol. 2019 Nov 4:JCO1901488. doi: 10.1200/JCO.19.01488. [Epub ahead of print]

PMID:
31682542
5.

[Simultaneous Repair for Aorto-iliac Occlusive Disease and Transcatheter Aortic Valve Implantation;Report of a Case].

Uchino H, Kimu C, Nakamura K, Kobayashi K, Shimanuki T, Sugawara S.

Kyobu Geka. 2019 Sep;72(9):690-693. Japanese.

PMID:
31506410
6.

Subgroup Analysis of Japanese Patients in a Phase III Study of Atezolizumab in Extensive-stage Small-cell Lung Cancer (IMpower133).

Nishio M, Sugawara S, Atagi S, Akamatsu H, Sakai H, Okamoto I, Takayama K, Hayashi H, Nakagawa Y, Kawakami T.

Clin Lung Cancer. 2019 Nov;20(6):469-476.e1. doi: 10.1016/j.cllc.2019.07.005. Epub 2019 Jul 31.

PMID:
31466854
7.

Comorbid depressive disorders and left-side dominant occlusal discomfort in patients with phantom bite syndrome.

Shinohara Y, Umezaki Y, Minami I, Watanabe M, Miura A, Mikutsuki L, Kawasaki K, Sugawara S, Trang TTH, Suga T, Watanabe T, Yoshikawa T, Takenoshita M, Motomura H, Toyofuku A.

J Oral Rehabil. 2019 Aug 9. doi: 10.1111/joor.12872. [Epub ahead of print]

PMID:
31398263
8.

Multicenter, placebo-controlled, double-blind, randomized study of fosnetupitant in combination with palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.

Sugawara S, Inui N, Kanehara M, Morise M, Yoshimori K, Kumagai T, Fukui T, Minato K, Iwashima A, Takeda Y, Kubota K, Saeki T, Tamura T.

Cancer. 2019 Nov 15;125(22):4076-4083. doi: 10.1002/cncr.32429. Epub 2019 Aug 5.

PMID:
31381152
9.

Severe acute pancreatitis 5 years after pancreaticoduodenectomy: A case report.

Ashitomi Y, Sugawara S, Takahashi R, Ashino K, Watanabe T, Hachiya O, Kimura W.

Int J Surg Case Rep. 2019;61:99-102. doi: 10.1016/j.ijscr.2019.07.045. Epub 2019 Jul 22.

10.

Interleukin-1 and histamine are essential for inducing nickel allergy in mice.

Bando K, Kuroishi T, Sugawara S, Endo Y.

Clin Exp Allergy. 2019 Oct;49(10):1362-1373. doi: 10.1111/cea.13467. Epub 2019 Aug 18.

PMID:
31325186
11.

Detectability of Malignant Lesions by Whole-Body Magnetic Resonance Imaging Using Whole-Body Integrated Positron Emission Tomography/Magnetic Resonance Imaging.

Ishii S, Miyajima M, Suenaga H, Sugawara S, Nemoto A, Ukon N, Nambu T, Kubo H, Oriuchi N, Ito H.

J Comput Assist Tomogr. 2019 Jul/Aug;43(4):664-670. doi: 10.1097/RCT.0000000000000882.

PMID:
31259851
12.

Retrospective Comparative Study of Absolute Ethanol with N-Butyl-2-Cyanoacrylate in Percutaneous Portal Vein Embolization.

Sugawara S, Arai Y, Sone M, Nara S, Kishi Y, Esaki M, Shimada K, Katai H.

J Vasc Interv Radiol. 2019 Aug;30(8):1215-1222. doi: 10.1016/j.jvir.2018.12.020. Epub 2019 Jun 13.

PMID:
31202679
13.

Feasibility of genomic profiling with next-generation sequencing using specimens obtained by image-guided percutaneous needle biopsy.

Sone M, Arai Y, Sugawara S, Kubo T, Itou C, Hasegawa T, Umakoshi N, Yamamoto N, Sunami K, Hiraoka N, Kubo T.

Ups J Med Sci. 2019 Apr;124(2):119-124. doi: 10.1080/03009734.2019.1607635.

14.

Survivorship Bias in Analyses of Immune Checkpoint Inhibitor Trials-In Reply.

Toi Y, Sugawara S.

JAMA Oncol. 2019 Jun 6. doi: 10.1001/jamaoncol.2019.1190. [Epub ahead of print] No abstract available.

PMID:
31169864
15.

Mechanisms underlying the induction of regulatory T cells by sublingual immunotherapy.

Tanaka Y, Fukumoto S, Sugawara S.

J Oral Biosci. 2019 Jun;61(2):73-77. doi: 10.1016/j.job.2019.02.001. Epub 2019 Mar 7. Review.

PMID:
31109864
16.

Role of intra-ventricular vortex in left ventricular ejection elucidated by echo-dynamography.

Tanaka M, Sakamoto T, Saijo Y, Katahira Y, Sugawara S, Nakajima H, Kurokawa T, Kanai H.

J Med Ultrason (2001). 2019 Oct;46(4):413-423. doi: 10.1007/s10396-019-00943-5. Epub 2019 May 10.

PMID:
31076894
17.

Corrigendum to "Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan" [Lung Cancer, 129 (March) (2019) 55-62].

Watanabe S, Yoshioka H, Sakai H, Hotta K, Takenoyama M, Yamada K, Sugawara S, Takiguchi Y, Hosomi Y, Tomii K, Niho S, Yamamoto N, Nishio M, Ohe Y, Kato T, Takahashi T, Kamada A, Suzukawa K, Omori Y, Enatsu S, Nakagawa K, Tamura T.

Lung Cancer. 2019 Jun;132:157-158. doi: 10.1016/j.lungcan.2019.04.010. Epub 2019 Apr 20. No abstract available.

18.

Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial.

Saito H, Fukuhara T, Furuya N, Watanabe K, Sugawara S, Iwasawa S, Tsunezuka Y, Yamaguchi O, Okada M, Yoshimori K, Nakachi I, Gemma A, Azuma K, Kurimoto F, Tsubata Y, Fujita Y, Nagashima H, Asai G, Watanabe S, Miyazaki M, Hagiwara K, Nukiwa T, Morita S, Kobayashi K, Maemondo M.

Lancet Oncol. 2019 May;20(5):625-635. doi: 10.1016/S1470-2045(19)30035-X. Epub 2019 Apr 8.

PMID:
30975627
19.

The motor engram as a dynamic change of the cortical network during early sequence learning: An fMRI study.

Hamano YH, Sugawara SK, Yoshimoto T, Sadato N.

Neurosci Res. 2019 Mar 30. pii: S0168-0102(18)30535-2. doi: 10.1016/j.neures.2019.03.004. [Epub ahead of print]

PMID:
30940459
20.

Upregulation of calcitonin gene-related peptide, neuronal nitric oxide synthase, and phosphorylated extracellular signal-regulated kinase 1/2 in the trigeminal ganglion after bright light stimulation of the eye in rats.

Okada S, Saito H, Matsuura Y, Mikuzuki L, Sugawara S, Onose H, Asaka J, Ohara K, Lee J, Iinuma T, Katagiri A, Iwata K.

J Oral Sci. 2019;61(1):146-155. doi: 10.2334/josnusd.18-0031.

21.

Development of multi-directional functional near-infrared spectroscopy system for human neuroimaging studies.

Shimokawa T, Ishii T, Takahashi Y, Mitani Y, Mifune H, Chubachi S, Satoh M, Oba Y, Adachi K, Sugawara S, Yamashita O.

Biomed Opt Express. 2019 Feb 22;10(3):1393-1404. doi: 10.1364/BOE.10.001393. eCollection 2019 Mar 1.

22.

Pharmacotherapeutic outcomes in atypical odontalgia: determinants of pain relief.

Tu TTH, Miura A, Shinohara Y, Mikuzuki L, Kawasaki K, Sugawara S, Suga T, Watanabe T, Aota Y, Umezaki Y, Takenoshita M, Toyofuku A.

J Pain Res. 2019 Feb 27;12:831-839. doi: 10.2147/JPR.S188362. eCollection 2019.

23.

Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC.

Sugawara S, Nakagawa K, Yamamoto N, Nokihara H, Ohe Y, Nishio M, Takahashi T, Goto K, Maemondo M, Ichinose Y, Seto T, Sakai H, Gemma A, Imamura F, Shingyoji M, Saka H, Inoue A, Takeda K, Okamoto I, Kiura K, Morita S, Tamura T.

Int J Clin Oncol. 2019 May;24(5):485-493. doi: 10.1007/s10147-019-01396-z. Epub 2019 Mar 4.

24.

Micro-ribonucleic acid expression signature of metastatic castration-resistant prostate cancer: Regulation of NCAPH by antitumor miR-199a/b-3p.

Arai T, Kojima S, Yamada Y, Sugawara S, Kato M, Yamazaki K, Naya Y, Ichikawa T, Seki N.

Int J Urol. 2019 Apr;26(4):506-520. doi: 10.1111/iju.13911. Epub 2019 Feb 28.

PMID:
30818424
25.

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan.

Watanabe S, Yoshioka H, Sakai H, Hotta K, Takenoyama M, Yamada K, Sugawara S, Takiguchi Y, Hosomi Y, Tomii K, Niho S, Yamamoto N, Nishio M, Ohe Y, Kato T, Takahashi T, Kamada A, Suzukawa K, Omori Y, Enatsu S, Nakagawa K, Tamura T.

Lung Cancer. 2019 Mar;129:55-62. doi: 10.1016/j.lungcan.2019.01.005. Epub 2019 Jan 16. Erratum in: Lung Cancer. 2019 Jun;132:157-158.

26.

Neural correlates of online cooperation during joint force production.

Abe MO, Koike T, Okazaki S, Sugawara SK, Takahashi K, Watanabe K, Sadato N.

Neuroimage. 2019 May 1;191:150-161. doi: 10.1016/j.neuroimage.2019.02.003. Epub 2019 Feb 7.

27.

Augmentation of Lipopolysaccharide-Induced Production of IL-1α and IL-1β in Mice Given Intravenous Zoledronate (a Nitrogen-Containing Bisphosphonate) and Its Prevention by Clodronate (a Non-nitrogen-containing Bisphosphonate).

Suzuki H, Bando K, Tada H, Kiyama T, Oizumi T, Funayama H, Sugawara S, Takahashi T, Endo Y.

Biol Pharm Bull. 2019;42(2):164-172. doi: 10.1248/bpb.b18-00408.

28.

Periodontal Regeneration by Allogeneic Transplantation of Adipose Tissue Derived Multi-Lineage Progenitor Stem Cells in vivo.

Venkataiah VS, Handa K, Njuguna MM, Hasegawa T, Maruyama K, Nemoto E, Yamada S, Sugawara S, Lu L, Takedachi M, Murakami S, Okura H, Matsuyama A, Saito M.

Sci Rep. 2019 Jan 29;9(1):921. doi: 10.1038/s41598-018-37528-0.

29.

Profiling Preexisting Antibodies in Patients Treated With Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer.

Toi Y, Sugawara S, Sugisaka J, Ono H, Kawashima Y, Aiba T, Kawana S, Saito R, Aso M, Tsurumi K, Suzuki K, Shimizu H, Domeki Y, Terayama K, Nakamura A, Yamanda S, Kimura Y, Honda Y.

JAMA Oncol. 2019 Mar 1;5(3):376-383. doi: 10.1001/jamaoncol.2018.5860.

PMID:
30589930
30.

Compact coil packing using a steerable microcatheter for a giant wide-necked pulmonary artery pseudoaneurysm.

Umakoshi N, Arai Y, Sone M, Sugawara S.

Interact Cardiovasc Thorac Surg. 2019 May 1;28(5):826-827. doi: 10.1093/icvts/ivy332.

PMID:
30561622
31.

Phase II Trial of Transarterial Embolization Using an n-Butyl-2-Cyanoacrylate/Lipiodol Mixture (JIVROSG-0802).

Sugawara S, Arai Y, Sone M, Ishiguchi T, Kitagawa A, Aramaki T, Sato R, Morishita H, Takeuchi Y, Inaba Y.

Cardiovasc Intervent Radiol. 2019 Apr;42(4):534-541. doi: 10.1007/s00270-018-2141-7. Epub 2018 Dec 6.

PMID:
30523386
32.

Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset.

Ohe Y, Imamura F, Nogami N, Okamoto I, Kurata T, Kato T, Sugawara S, Ramalingam SS, Uchida H, Hodge R, Vowler SL, Walding A, Nakagawa K.

Jpn J Clin Oncol. 2019 Jan 1;49(1):29-36. doi: 10.1093/jjco/hyy179.

33.

[Application of Lectin from Catfish Eggs to Cancer Therapy: A Fundamental Study].

Sugawara S.

Yakugaku Zasshi. 2018;138(12):1451-1459. doi: 10.1248/yakushi.18-00128. Review. Japanese.

34.

Effects of the 1975 Japanese diet on the gut microbiota in younger adults.

Kushida M, Sugawara S, Asano M, Yamamoto K, Fukuda S, Tsuduki T.

J Nutr Biochem. 2019 Feb;64:121-127. doi: 10.1016/j.jnutbio.2018.10.011. Epub 2018 Nov 1.

PMID:
30502656
35.

Prosocial behavior toward estranged persons modulates the interaction between midline cortical structures and the reward system.

Kawamichi H, Sugawara SK, Hamano YH, Makita K, Kochiyama T, Kikuchi Y, Ogino Y, Saito S, Sadato N.

Soc Neurosci. 2019 Oct;14(5):618-630. doi: 10.1080/17470919.2018.1553797. Epub 2018 Dec 9.

PMID:
30484373
36.

Pirin: a potential novel therapeutic target for castration-resistant prostate cancer regulated by miR-455-5p.

Arai T, Kojima S, Yamada Y, Sugawara S, Kato M, Yamazaki K, Naya Y, Ichikawa T, Seki N.

Mol Oncol. 2019 Feb;13(2):322-337. doi: 10.1002/1878-0261.12405. Epub 2018 Dec 21.

37.

Influence of Japanese diet consumption during pregnancy and lactation on lipid metabolism in offspring.

Ishikawa H, Guo X, Sugawara S, Iwagaki Y, Yamamoto K, Konno A, Nishiuchi M, Tsuduki T.

Nutrition. 2019 Feb;58:69-76. doi: 10.1016/j.nut.2018.06.006. Epub 2018 Jul 12.

PMID:
30388605
38.

Sialic Acid-Binding Lectin from Bullfrog Eggs Exhibits an Anti-Tumor Effect Against Breast Cancer Cells Including Triple-Negative Phenotype Cells.

Tatsuta T, Sato S, Sato T, Sugawara S, Suzuki T, Hara A, Hosono M.

Molecules. 2018 Oct 21;23(10). pii: E2714. doi: 10.3390/molecules23102714.

39.

Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.

Paz-Ares L, Luft A, Vicente D, Tafreshi A, Gümüş M, Mazières J, Hermes B, Çay Şenler F, Csőszi T, Fülöp A, Rodríguez-Cid J, Wilson J, Sugawara S, Kato T, Lee KH, Cheng Y, Novello S, Halmos B, Li X, Lubiniecki GM, Piperdi B, Kowalski DM; KEYNOTE-407 Investigators.

N Engl J Med. 2018 Nov 22;379(21):2040-2051. doi: 10.1056/NEJMoa1810865. Epub 2018 Sep 25.

40.

No recovery of replication-competent HIV-1 from human liver macrophages.

Kandathil AJ, Sugawara S, Goyal A, Durand CM, Quinn J, Sachithanandham J, Cameron AM, Bailey JR, Perelson AS, Balagopal A.

J Clin Invest. 2018 Oct 1;128(10):4501-4509. doi: 10.1172/JCI121678. Epub 2018 Sep 10.

41.

Effects of Japanese diet in combination with exercise on visceral fat accumulation.

Asano M, Iwagaki Y, Sugawara S, Kushida M, Okouchi R, Yamamoto K, Tsuduki T.

Nutrition. 2019 Jan;57:173-182. doi: 10.1016/j.nut.2018.05.023. Epub 2018 Jun 19.

PMID:
30170306
42.

Molecular pathogenesis of renal cell carcinoma: Impact of the anti-tumor miR-29 family on gene regulation.

Yamada Y, Sugawara S, Arai T, Kojima S, Kato M, Okato A, Yamazaki K, Naya Y, Ichikawa T, Seki N.

Int J Urol. 2018 Nov;25(11):953-965. doi: 10.1111/iju.13783. Epub 2018 Aug 28.

43.

Clinical characteristics and course of oral somatic delusions: a retrospective chart review of 606 cases in 5 years.

Umezaki Y, Miura A, Shinohara Y, Mikuzuki L, Sugawara S, Kawasaki K, Tu TT, Watanabe T, Suga T, Watanabe M, Takenoshita M, Yoshikawa T, Uezato A, Nishikawa T, Hoshiko K, Naito T, Motomura H, Toyofuku A.

Neuropsychiatr Dis Treat. 2018 Aug 13;14:2057-2065. doi: 10.2147/NDT.S167527. eCollection 2018.

44.

Evaluation of stent placement for vena cava syndrome: phase II trial and phase III randomized controlled trial.

Takeuchi Y, Arai Y, Sone M, Sugawara S, Aramaki T, Sato R, Kichikawa K, Tanaka T, Morishita H, Ito T, Yamakado K, Baba Y, Kobayashi T.

Support Care Cancer. 2019 Mar;27(3):1081-1088. doi: 10.1007/s00520-018-4397-5. Epub 2018 Aug 15.

PMID:
30112721
45.

CMPK2 and BCL-G are associated with type 1 interferon-induced HIV restriction in humans.

El-Diwany R, Soliman M, Sugawara S, Breitwieser F, Skaist A, Coggiano C, Sangal N, Chattergoon M, Bailey JR, Siliciano RF, Blankson JN, Ray SC, Wheelan SJ, Thomas DL, Balagopal A.

Sci Adv. 2018 Aug 1;4(8):eaat0843. doi: 10.1126/sciadv.aat0843. eCollection 2018 Aug.

46.

Third DWF1 paralog in Solanaceae, sterol Δ24-isomerase, branches withanolide biosynthesis from the general phytosterol pathway.

Knoch E, Sugawara S, Mori T, Poulsen C, Fukushima A, Harholt J, Fujimoto Y, Umemoto N, Saito K.

Proc Natl Acad Sci U S A. 2018 Aug 21;115(34):E8096-E8103. doi: 10.1073/pnas.1807482115. Epub 2018 Aug 6.

47.

Phase I Study Evaluating the Combination of Afatinib with Carboplatin and Pemetrexed After First-line EGFR-TKIs.

Watanabe S, Yamaguchi OU, Masumoto AI, Maeno Y, Kawashima Y, Ishimoto O, Sugawara S, Yoshizawa H, Kikuchi T, Nukiwa T, Kobayashi K.

Anticancer Res. 2018 Aug;38(8):4699-4704. doi: 10.21873/anticanres.12776.

PMID:
30061238
48.

[A Case Report of Surgery and Chemotherapy for a Patient with Rapidly Progressing Breast Cancer during Pregnancy].

Hazama Y, Nakai Y, Sugawara S, Nomura T, Matsumoto K, Matsumoto R, Sugihara M, Ishida T, Murata S, Murata T, Nakamura T, Moriya T, Kurebayashi J, Shimoya K.

Gan To Kagaku Ryoho. 2018 May;45(5):847-850. Japanese.

PMID:
30026449
49.

HIV-1 Infection and Type 1 Interferon: Navigating Through Uncertain Waters.

Sugawara S, Thomas DL, Balagopal A.

AIDS Res Hum Retroviruses. 2019 Jan;35(1):25-32. doi: 10.1089/AID.2018.0161. Epub 2018 Aug 15.

PMID:
29999412
50.

Regulation of antitumor miR-144-5p targets oncogenes: Direct regulation of syndecan-3 and its clinical significance.

Yamada Y, Arai T, Kojima S, Sugawara S, Kato M, Okato A, Yamazaki K, Naya Y, Ichikawa T, Seki N.

Cancer Sci. 2018 Sep;109(9):2919-2936. doi: 10.1111/cas.13722. Epub 2018 Jul 28.

Supplemental Content

Loading ...
Support Center